Literature DB >> 35006509

Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration.

Jonathan Pastrana Del Valle1,2,3, Nathanael R Fillmore3,4, George Molina3,5, Mark Fairweather3,5, Jiping Wang3,5, Thomas E Clancy3,5, Stanley W Ashley3,5, Richard D Urman3,6, Edward E Whang1,3,5, Jason S Gold7,8,9.   

Abstract

BACKGROUND: Disparities based on socioeconomic factors such as race, ethnicity, marital status, and insurance status are associated with pancreatic cancer resection, but these disparities are usually not observed for survival after resection. It is unknown if there are disparities when patients undergo their treatment in a non-fee-for-service, equal-access healthcare system such as the Veterans Health Administration (VHA).
METHODS: Patients having T1-T3 M0 pancreatic adenocarcinoma diagnosed between 2006 and 2017 were identified from the VHA Corporate Data Warehouse. Socioeconomic, demographic, and tumor variables associated with resection and survival were assessed.
RESULTS: In total, 2580 patients with early-stage pancreatic cancer were identified. The resection rate was 36.5%. Surgical resection was independently associated with younger age [odds ratio (OR) 0.94, p < 0.001], White race (OR 1.35, p = 0.028), married status (OR 1.85, p = 0.001), and employment status (retired vs. unemployed, OR 1.41, p = 0.008). There were no independent associations with Hispanic ethnicity, geographic region, or Social Deprivation Index. Resection was associated with significantly improved survival (median 21 vs. 8 months, p = 0.001). Among resected patients, survival was independently associated with younger age (HR 1.019, p = 0.002), geographic region (South vs. Pacific West, HR 0.721, p = 0.005), and employment (employed vs. unemployed, HR 0.752, p = 0.029). Race, Hispanic ethnicity, marital status, and Social Deprivation Index were not independently associated with survival after resection.
CONCLUSIONS: Race, marital status, and employment status are independently associated with resection of pancreatic cancer in the VHA, whereas geographic region and employment status are independently associated with survival after resection. Further studies are warranted to determine the basis for these inequities.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Mesh:

Year:  2022        PMID: 35006509     DOI: 10.1245/s10434-021-11250-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  42 in total

Review 1.  Pancreatic cancer disparities in African Americans.

Authors:  Shumaila N Khawja; Somala Mohammed; Eric J Silberfein; Benjamin L Musher; William E Fisher; George Van Buren
Journal:  Pancreas       Date:  2015-05       Impact factor: 3.327

2.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

3.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

4.  The Impact of Residential Segregation on Pancreatic Cancer Diagnosis, Treatment, and Mortality.

Authors:  Barbara Aldana Blanco; Michael Poulson; Kelly M Kenzik; David B McAneny; Jennifer F Tseng; Teviah E Sachs
Journal:  Ann Surg Oncol       Date:  2020-11-01       Impact factor: 5.344

5.  The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.

Authors:  Yasser Shaib; Jessica Davila; Chris Naumann; Hashem El-Serag
Journal:  Am J Gastroenterol       Date:  2007-03-31       Impact factor: 10.864

6.  Underuse of curative surgery for early stage upper gastrointestinal cancers in the United States.

Authors:  Lee J McGhan; David A Etzioni; Richard J Gray; Barbara A Pockaj; Kathryn E Coan; Nabil Wasif
Journal:  J Surg Res       Date:  2012-03-30       Impact factor: 2.192

7.  National failure to operate on early stage pancreatic cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

8.  African-Americans and Indigenous Peoples Have Increased Burden of Diseases of the Exocrine Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Aya Cervantes; Ellen K Waymouth; Maxim S Petrov
Journal:  Dig Dis Sci       Date:  2018-09-27       Impact factor: 3.199

9.  Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals.

Authors:  Karl Y Bilimoria; David J Bentrem; James S Tomlinson; Ryan P Merkow; Andrew K Stewart; Clifford Y Ko; Jay B Prystowsky; Mark S Talamonti
Journal:  Am J Surg       Date:  2007-11       Impact factor: 2.565

10.  Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.

Authors:  Mia Shapiro; Qi Chen; Qin Huang; Valia A Boosalis; Charles H Yoon; Mandeep S Saund; Edward E Whang; Jason S Gold
Journal:  JAMA Surg       Date:  2016-04       Impact factor: 14.766

View more
  1 in total

Review 1.  Advances and Remaining Challenges in the Treatment for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma.

Authors:  Megan L Sulciner; Stanley W Ashley; George Molina
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.